| P50 | author | Mustapha Chamekh | Q99593440 |
| | Olivier Denis | Q99707923 |
| P2093 | author name string | Marta Romano | |
| | Georges Casimir | |
| | Maud Deny | |
| P2860 | cites work | Blood monocytes: development, heterogeneity, and relationship with dendritic cells | Q24314793 |
| | MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development | Q24620604 |
| | Requirement of bic/microRNA-155 for normal immune function | Q24656120 |
| | Monocyte Heterogeneity: Consequences for Monocyte-Derived Immune Cells | Q26740174 |
| | Widespread changes in protein synthesis induced by microRNAs | Q27860886 |
| | Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? | Q27860893 |
| | Increased Risk of Group B Streptococcus Invasive Infection in HIV-Exposed but Uninfected Infants: A Review of the Evidence and Possible Mechanisms | Q28067423 |
| | Regulation of progenitor cell proliferation and granulocyte function by microRNA-223 | Q28510667 |
| | Monocyte and macrophage heterogeneity | Q29547438 |
| | Blood monocytes consist of two principal subsets with distinct migratory properties | Q29614286 |
| | Alternative activation of macrophages: mechanism and functions | Q29614350 |
| | Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production | Q39277512 |
| | Role of gamma interferon in a neonatal mouse model of group B streptococcal disease | Q39825588 |
| | Delivery of biologically active anti-inflammatory cytokines IL-10 and IL-1ra in vivo by the Shigella type III secretion apparatus | Q40005415 |
| | Hematopoietic-specific microRNA expression in human cells | Q40361902 |
| | Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 plasma levels in neonatal sepsis | Q40719261 |
| | Plasma exosomal miR-223 expression regulates inflammatory responses during cardiac surgery with cardiopulmonary bypass | Q41541980 |
| | Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. | Q43857650 |
| | Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. | Q44872292 |
| | Ly6G+ neutrophil-derived miR-223 inhibits the NLRP3 inflammasome in mitochondrial DAMP-induced acute lung injury | Q47709768 |
| | Neutrophil transfer of miR-223 to lung epithelial cells dampens acute lung injury in mice | Q48319896 |
| | The Phagocytic Function of Macrophage-Enforcing Innate Immunity and Tissue Homeostasis. | Q48332393 |
| | MicroRNA expression profiles of bovine monocyte-derived macrophages infected in vitro with two strains of Streptococcus agalactiae. | Q52595686 |
| | Expression profiles of miRNAs from bovine mammary glands in response to Streptococcus agalactiae-induced mastitis. | Q53100062 |
| | Gene expression networks in COPD: microRNA and mRNA regulation. | Q54347289 |
| | Lung Interstitial Macrophages: Past, Present, and Future. | Q55379939 |
| | Role of miR-223 in the pathophysiology of liver diseases | Q58695698 |
| | Production of tumor necrosis factor by human cells in vitro and in vivo, induced by group B streptococci | Q72866597 |
| | A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation | Q84117546 |
| | MicroRNA miR-223 as regulator of innate immunity | Q89405421 |
| | Gene silencing by microRNAs: contributions of translational repression and mRNA decay | Q29615825 |
| | Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids | Q33291235 |
| | Induction and termination of inflammatory signaling in group B streptococcal sepsis | Q33608933 |
| | MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation | Q34079793 |
| | Serum miR-146a and miR-223 as potential new biomarkers for sepsis. | Q34100861 |
| | Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis | Q34245437 |
| | Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1β production in macrophages by targeting STAT3. | Q34398929 |
| | Identification of most stable endogenous control genes for microRNA quantification in the developing mouse lung | Q34450681 |
| | Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection. | Q34521810 |
| | Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci | Q34529051 |
| | An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. | Q34625798 |
| | Macrophage defences against respiratory tract infections. | Q34628945 |
| | MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases | Q34772318 |
| | MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. | Q34786558 |
| | microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification | Q34922055 |
| | miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis | Q35014077 |
| | Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivo | Q35082207 |
| | MicroRNA-223 regulates granulopoiesis but is not required for HSC maintenance in mice | Q35203490 |
| | A Protocol for the Comprehensive Flow Cytometric Analysis of Immune Cells in Normal and Inflamed Murine Non-Lymphoid Tissues | Q35944589 |
| | MicroRNA-223 Induced Repolarization of Peritoneal Macrophages Using CD44 Targeting Hyaluronic Acid Nanoparticles for Anti-Inflammatory Effects | Q36009269 |
| | Choriodecidual Group B Streptococcal Infection Induces miR-155-5p in the Fetal Lung in Macaca nemestrina | Q36053552 |
| | Group B streptococcal infections in elderly adults | Q36233889 |
| | MicroRNAs and immunity: tiny players in a big field | Q36739025 |
| | Micromanagement of the immune system by microRNAs | Q37060274 |
| | MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment | Q37259224 |
| | Physiological and pathological roles for microRNAs in the immune system | Q37680666 |
| | Diverse macrophage populations mediate acute lung inflammation and resolution | Q37707609 |
| | miR-223: infection, inflammation and cancer | Q38114927 |
| | The multifaceted functions of neutrophils | Q38139589 |
| | miR-223: An inflammatory oncomiR enters the cardiovascular field | Q38198420 |
| | Monocyte homeostasis and the plasticity of inflammatory monocytes. | Q38223022 |
| | Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. | Q38795315 |
| | Monocyte Conversion During Inflammation and Injury. | Q38986677 |
| | NLRP3 inflammasome activity is negatively controlled by miR-223. | Q39277506 |
| P921 | main subject | Streptococcus agalactiae | Q132949 |
| P577 | publication date | 2020-09-21 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Progressive control of Streptococcus agalactiae-induced innate inflammatory response is associated with time-course expression of microRNA-223 by neutrophils | |